Diets and weight change to study how obesity leads to insulin resistance
Studies how weight change and diets affect insulin resistance.
Key facts
- Who runs it
- Stanford University
- Where
- Stanford, United StatesSee the site
- Trial code
- Registry title
- Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
- Status
- Recruiting
- People taking part
- 110 people, planned
- Started
- 31 Jan 2019
- Expected to end
- 30 Dec 2026
- Type of study
- Interventional, 3 groups
- Treatments tested
- Dietary Intervention Mediterranean Low Carbohydrate Diet
- Dietary Intervention Standard Low Carbohydrate Diet
- Dietary Intervention Standard Low Fat Diet
- Record updated
- 4 December 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 35 to 65 with a BMI of 25-35 kg/m2, stable weight and no diabetes, for a 12-week diet and weight study.
- Age
- 35 to 65 years
- Sex
- All sexes can join.
- Disease stage
- No diabetes. BMI of 25-35 kg/m2.
- Earlier treatment
- People cannot have used weight loss medication, statins or oral steroids.
Main reasons for not taking part
- Diabetes, or fasting glucose of 126 mg/dL (7 mmol/L) or more
- Major organ disease
- History of liposuction or bariatric surgery
- Active eating or psychiatric disorder
- Pregnancy or lactation, heavy alcohol use
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Age 35-65
- BMI 25-35 kg/m2
- Stable body weight
- Nondiabetic
Who cannot take part
- use of weight loss medication, statins, or oral steroids; Clinical screening exclusions
- diabetes
- major organ disease
- history of liposuction or bariatric surgery
- active eating or psychiatric disorder
- fasting glucose >/= 126 mg/dL
- Patients with
- pregnancy or lactation, heavy alcohol use
- recent change in weight (over the past 12 weeks)
- hematocrit < 33%
- blood pressure >160/100 mmHg
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 35 and 65 years old?
Where in United States
- Stanford UniversityStanford, United StatesContact: Ekrem M Ayhan, BSTaking people
About the trial
What the trial wants to find out
This 12-week controlled diet and weight intervention study seeks to define the molecular pathways that link excess body weight to the development of insulin resistance (IR). Blood, adipose and stool are sampled at three timepoints; baseline, peak weight (4 weeks) and post weight loss to monitor changes in cellular processes. Additionally, direct insulin sensitivity testing, and radiological measurement of visceral fat and intrahepatic fat content is measured at three timepoints to correlate clinical indices with cellular changes.
The 3 groups in the trial
- Mediterranean Low Carbohydrate DietTreatment being tested
Assigned participants will receive instruction by a registered dietitian on a diet that is high in unsaturated fats and low in carbohydrates. Total caloric intake will be adjusted to induce a supervised metabolic challenge defined as weight gain of approximately 2.5 kg over 5 weeks followed by 3-5kg weight loss over 8 weeks.
Treatment: Dietary Intervention Mediterranean Low Carbohydrate Diet
- Standard Low Carbohydrate DietTreatment being tested
Assigned participants will receive instruction by a registered dietitian on a low carbohydrate diet that is high in fats found in the typical American diet. Total caloric intake will be adjusted to induce a supervised metabolic challenge defined as weight gain of approximately 2.5 kg over 5 weeks followed by 3-5kg weight loss over 8 weeks.
Treatment: Dietary Intervention Standard Low Carbohydrate Diet
- Low Fat, Healthy Carbohydrate DietTreatment being tested
Assigned participants will receive instruction by a registered dietitian on a low fat diet that is high in complex carbohydrates. Total caloric intake will be adjusted to induce a supervised metabolic challenge defined as weight gain of approximately 2.5 kg over 5 weeks followed by 3-5kg weight loss over 8 weeks.
Treatment: Dietary Intervention Standard Low Fat Diet
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
- Plain-language title
- Diets and weight change to study how obesity leads to insulin resistanceGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT05165706, who can take part
- Record updated
- 4 December 2024